Key Takeaways
- Shares of LRCX reached a record peak of $275.99, climbing 5.56% during the trading session
- Year-over-year performance shows a remarkable 252% gain
- Wall Street analysts have boosted their price projections to between $310 and $340
- Senior Vice President Neil Fernandes divested $4.6M worth of shares on May 1 through a pre-arranged 10b5-1 plan
- U.S. export controls targeting China’s Hua Hong create potential regulatory challenges
Shares of Lam Research (LRCX) climbed to a record level of $275.99 on May 5, 2026, posting a single-day gain exceeding 5.5%. This surge caps a twelve-month period that delivered a stunning 252% total return, propelling the semiconductor equipment manufacturer’s market capitalization to $343 billion.
Lam Research Corporation, LRCX
Top-line growth has accelerated approximately 27% during the trailing twelve-month period. The firm boasts a Piotroski Score of 9—the highest possible rating for financial strength according to InvestingPro metrics.
Currently, shares are valued at a price-to-earnings multiple of 48.75. InvestingPro’s valuation models suggest LRCX may be trading above its Fair Value benchmark.
Several major investment firms have recently revised their forecasts upward. Stifel increased its price objective to $325 following fiscal third-quarter results that exceeded both the firm’s projections and Street consensus. The Buy recommendation remains intact.
TD Cowen pushed even higher, establishing a $340 target. The firm highlighted expanding market share in both foundry operations and DRAM production, alongside anticipated increases in NAND wafer fabrication equipment investment.
Cantor Fitzgerald maintained its Overweight stance with a $320 price target. The firm referenced an enhanced outlook for wafer fabrication equipment throughout calendar 2026, forecasting sector expansion of no less than 27%.
UBS reaffirmed its Buy rating with a $310 objective, characterizing LRCX as positioned at the start of an artificial intelligence-fueled expansion phase.
Executive Stock Transaction Captures Market Focus
Senior Vice President Neil Fernandes executed a sale of 18,170 shares on May 1 at $255.14 per share, generating proceeds of approximately $4.64 million. This transaction occurred under a Rule 10b5-1 trading arrangement established by Fernandes on November 17, 2025.
Following this divestiture, Fernandes maintains direct ownership of 66,129 shares. Additionally, he controls slightly more than 1,015 shares held indirectly via a 401(k) retirement account.
Such pre-scheduled transactions are standard practice for corporate leadership and typically don’t signal negative sentiment regarding future performance.
Export Controls to China Create Headwinds
The path forward isn’t without obstacles. The U.S. Department of Commerce implemented new export restrictions on chipmaking equipment destined for Hua Hong, China’s second-largest semiconductor manufacturer. Lam Research numbered among the American equipment suppliers impacted by these measures.
These limitations triggered temporary declines across chip equipment stocks when initially announced. The full financial ramifications for LRCX from these regulatory constraints remain to be determined.
Fiscal fourth-quarter guidance surpassed analyst expectations. The company has already achieved profitability and revenue benchmarks that were initially projected for calendar year 2028.
LRCX’s fiscal third-quarter performance exceeded both Stifel’s internal forecasts and broader Wall Street consensus figures, catalyzing the latest round of upward price target revisions from analysts.
Shares concluded trading on May 5 at the record level of $275.99.
